In silico identification of common putative drug targets in Leptospira interrogans

Journal of Chemical Biology

Volumn 3, Issue 4, 2010, Pages 165-173

  Amineni, U ^a   Pradhan, D ^b   Marisetty, H ^b  

^a SRI VENKATESWARA INSTITUTE OF MEDICAL SCIENCES   (India)

^b AGRICULTURAL RESEARCH STATION   (India)

Author keywords

KEGG; Leptospirosis; Novel drug targets; Subtractive genomics approach

Indexed keywords

EID: 83555178130     PISSN: 18646158     EISSN: 18646166     Source Type: Journal    
DOI: 10.1007/s12154-010-0039-1     Document Type: Article

References (39)

1. Chopra I, Schofield C, Everett M, O'Neill A, Miller K, Wilcox M, Frère JM, Dawson M, Czaplewski L, Urleb U, Courvalin P (2008) Treatment of healthcare-associated infections caused by Gram-negative bacteria: a consensus statement. Lancet Infect Dis 8:133-139
2. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, Santos CS, Croda J, Homma A, Dellagostin OA, Haake DA, Reis MG, Ko AI (2007) The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25:6277-6286
3. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3:757-771
4. Trueba G, Zapata S, Madrid K, Cullen P, Haake D (2004) Cell aggregation: a mechanism of pathogenic Leptospira to survive in fresh water. Int Microbiol 7:35-40
5. Levett PN (2001) Leptospirosis. Clin Microbiol Rev 14:296-326
6. Cacciapuoti B, Vellucci A, Ciceroni L, Pinto A, Taggi F (1987) Prevalence of leptospirosis in man: a pilot survey. Eur J Epidemiol 3:137-142
7. Everard CO, Hayes RJ, Edwards CN (1989) Leptospiral infection in school children from Trinidad and Barbados. Epidemiol Infect 103:143-156
8. Faine S, Adler B, Bolin C, Perolat P (1999) Appendix 2 species and serovar list. In: Leptospira and leptospirosis, 2nd edn. Medisci, Melbourne, Australia, pp 138-139
9. Farr RW (1995) Leptospirosis. Clin Infect Dis 21:1-6
10. Guidugli F, Castro AA, Atallah (2000) Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev 4:CD001305
11. Wang Z, Jin L, Wegrzyn A (2007) Leptospirosis vaccines. Microb Cell Fact 6:39
12. Umamaheswari A, Pradhan D, Priyadarshini IV, Subramanyam G (2008) In silico putative drug targets in Leptospira interrogans and homology modeling of UDP-N-acetylglucosamine 1-carboxyvinyltransferase MurA. Gen Med 2:295
13. Anishetty S, Pulimi M, Pennathur G (2005) Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Comput Biol Chem 29:368-378
14. Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H, Zhang YX, Xiong H, Lu G, Lu LF, Jiang HQ, Jia J, Tu YF, Jiang JX, Gu WY, Zhang YQ, Cai Z, Sheng HH, Yin HF, Zhang Y, Zhu GF, Wan M, Huang HL, Qian Z, Wang SY, Ma W, Yao ZJ, Shen Y, Qiang BQ, Xia QC, Guo XK, Danchin A, Saint Girons I, Somerville RL, Wen YM, Shi MH, Chen Z, Xu JG, Zhao GP (2003) Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 422:888-893
15. Nascimento AL, Verjovski-Almeida S, Van Sluys MA, Monteiro-Vitorello CB, Camargo LE, Digiampietri LA, Harstkeerl RA, Ho PL, Marques MV, Oliveira MC, Setubal JC, Haake DA, Martins EA (2004) Genome features of Leptospira interrogans serovar Copenhageni. Braz J Med Biol Res 37:459-477
16. Zhang R, Ou HY, Zhang CT (2004) DEG: A database of essential genes. Nucleic Acids Res 32:D271-D272
17. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389-3402
18. Kanehisa M, Goto S (2000) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28:27-30
19. Lu Z, Szafron D, Greiner R, Lu P, Wishart DS, Poulin B, Anvik J, Macdonell C, Eisner R (2004) Predicting subcellular localization of proteins using machine-learned classifiers. Bioinformatics 20:547-556
20. Gardy JL, Laird MR, Chen F, Rey S, Walsh CJ, Ester M, Brinkman FSL (2005) PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 21:617-623
21. World Health Organization (2002) Deaths by cause, sex and mortality stratum in WHO Regions, estimates for 2001. The World Health Report
22. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE Jr (2004) Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 38:1279-1286
23. Bansal AK (2005) Bioinformatics in microbial biotechnology-a mini review. Microb Cell Fact 4:19
24. Allsop AE, Brooks G, Bruton G, Coulton S, Edwards PD, Hatton IK, Kaura AC, McLean SD, Pearson ND, Smale TC, Southgate R (1995) Penem inhibitors of bacterial signal peptidase. Bioorganic Bioorg Med Chem Lett 5:443-448
25. Sakharkar KR, Sakharkar MK, Chow VT (2004) A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In Silico Biol 4:355-360
26. Dutta A, Singh SK, Ghosh P, Mukherjee R, Mitter S, Bandopadhyay D (2006) In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. In Silico Biol 6:43-47
27. Chong CE, Lim BS, Nathan S, Mohamed R (2006) In silico analysis of Burkholderia pseudomallei genome sequence for potential drug targets. In Silico Biol 6:341-346
28. Barh D, Kumar A (2009) In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae. In Silico Biol 9:225-231
29. Rakesh S, Pradhan D, Umamaheswari A (2009) In silico approach for future development of subunit vaccines against Leptospira interrogans serovar Lai. Int J Bioinformatics Res 1:85-92
30. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71:635-700
31. Taylor PL, Blakely KM, de Leon GP, Walker JR, McArthur F, Evdokimova E, Zhang K, Valvano MA, Wright GD, Junop MS (2008) Structure and function of sedoheptulose-7-phosphate isomerase, a critical enzyme for lipopolysaccharide biosynthesis and a target for antibiotic adjuvants. J Biol Chem 283:2835-2845
32. El Zoeiby A, Sanschagrin F, Levesque RC (2003) Structure and function of the Mur enzymes: development of novel inhibitors. Mol Microbiol 47:1-12
33. Strancar K, Blanot D, Gobec S (2006) Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD. Bioorg Med Chem Lett 16:343-348
34. Humljan J, Kotnik M, Contreras-Martel C, Blanot D, Urleb U, Dessen A, Solmajer T, Gobec S (2008) Novel naphthalene-Nsulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme. J Med Chem 51:7486-7494
35. Perdih A, Kovac A, Wolber G, Blanot D, Gobec S, Solmajer T (2009) Discovery of novel benzene 1, 3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structurebased virtual screening approach. Bioorg Med Chem Lett 19:2668-2673
36. Yu HB, Srinivasa Rao PS, Lee HC, Vilches S, Merino S, Tomas JM, Leung KY (2004) A Type III secretion system is required for Aeromonas hydrophila AH-1 pathogenesis. Infect Immun 72:1248-1256
37. Sandkvist M (2001) Type II secretion and pathogenesis. Infect Immun 69:3523-3535
38. Barrett JF, Hoch JA (1998) Two-component signal transduction as a target for microbial anti-infective therapy. Antimicrob Agents Chemother 42:1529-1536
39. Cai XH, Zhang Q, Shi SY, Ding DF (2005) Searching for potential drug targets in two-component and phosphorelay signaltransduction systems using three-dimensional cluster analysis. Acta Biochim Biophys Sin 37:293-302